Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6O5Z

Crystal Structure of the human MLKL pseudokinase domain bound to compound 2

Summary for 6O5Z
Entry DOI10.2210/pdb6o5z/pdb
DescriptorMixed lineage kinase domain-like protein, 1,2-ETHANEDIOL, 1-[2-fluoranyl-5-(trifluoromethyl)phenyl]-3-[4-[methyl-[2-[(3-sulfamoylphenyl)amino]pyrimidin-4-yl]amino]phenyl]urea, ... (4 entities in total)
Functional Keywordspseudokinase, inhibitor, necroptosis, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight66359.38
Authors
Cowan, A.D.,Murphy, J.M.,Pierotti, C.L.,Lessene, G.L.,Czabotar, P.E. (deposition date: 2019-03-04, release date: 2020-09-16, Last modification date: 2023-10-11)
Primary citationPierotti, C.L.,Tanzer, M.C.,Jacobsen, A.V.,Hildebrand, J.M.,Garnier, J.M.,Sharma, P.,Lucet, I.S.,Cowan, A.D.,Kersten, W.J.A.,Luo, M.X.,Liang, L.Y.,Fitzgibbon, C.,Garnish, S.E.,Hempel, A.,Nachbur, U.,Huang, D.C.S.,Czabotar, P.E.,Silke, J.,van Delft, M.F.,Murphy, J.M.,Lessene, G.
Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.
Acs Chem.Biol., 15:2702-2713, 2020
Cited by
PubMed Abstract: Necroptosis is an inflammatory form of programmed cell death that has been implicated in various human diseases. Compound is a more potent analogue of the published compound and inhibits necroptosis in human and murine cells at nanomolar concentrations. Several target engagement strategies were employed, including cellular thermal shift assays (CETSA) and diazirine-mediated photoaffinity labeling via a bifunctional photoaffinity probe derived from compound . These target engagement studies demonstrate that compound binds to all three necroptotic effector proteins (mixed lineage kinase domain-like protein (MLKL), receptor-interacting serine/threonine protein kinase 1 (RIPK1) and receptor-interacting serine/threonine protein kinase 3 (RIPK3)) at different levels and in cells. Compound also shows efficacy in a murine model of systemic inflammatory response syndrome (SIRS).
PubMed: 32902249
DOI: 10.1021/acschembio.0c00482
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.285 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon